U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Name Type Language
IZURALIMAB
USAN   INN  
Official Name English
IMMUNOGLOBULIN HALF-IG G1-KAPPA/SCFV-H-CH2-CH3, ANTI-(HOMO SAPIENS ICOS (INDUCIBLE T-CELL COSTIMULATORY, ACTIVATION-INDUCIBLE LYMPHOCYTE IMMUNOMEDIATORY MOLECULE, AILIM, CD278)) AND ANTI-(HOMO SAPIENS PDCD1 (PROGRAMMED CELL DEATH 1, PD-1, PD1, CD279)), M
Common Name English
IZURALIMAB [USAN]
Common Name English
IMMUNOGLOBULIN, ANTI-(HUMAN PROGRAMMED CELL DEATH 1) (HUMAN-MUS MUSCULUS MONOCLONAL XMAB23104 SINGLE-CHAIN VARIABLE FRAGMENT VL-LINKER-VH) FUSION PROTEIN WITH IMMUNOGLOBULIN G1 (HUMAN .GAMMA.1-CHAIN C-REGION C-TERMINAL FRAGMENT), (260->234'),(263->237')-
Common Name English
izuralimab [INN]
Common Name English
XMAB23104
Code English
Izuralimab [WHO-DD]
Common Name English
XMAB-23104
Code English
Code System Code Type Description
NCI_THESAURUS
C157578
Created by admin on Sat Dec 16 15:07:59 GMT 2023 , Edited by admin on Sat Dec 16 15:07:59 GMT 2023
PRIMARY
CAS
2329669-80-7
Created by admin on Sat Dec 16 15:07:59 GMT 2023 , Edited by admin on Sat Dec 16 15:07:59 GMT 2023
PRIMARY
FDA UNII
9D2R4T39AY
Created by admin on Sat Dec 16 15:07:59 GMT 2023 , Edited by admin on Sat Dec 16 15:07:59 GMT 2023
PRIMARY
INN
11466
Created by admin on Sat Dec 16 15:07:59 GMT 2023 , Edited by admin on Sat Dec 16 15:07:59 GMT 2023
PRIMARY
USAN
JK-25
Created by admin on Sat Dec 16 15:07:59 GMT 2023 , Edited by admin on Sat Dec 16 15:07:59 GMT 2023
PRIMARY
ACTIVE MOIETY
IZURALIMAB
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966